Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor
发育重编程是预后良好型肾母细胞瘤化疗耐药的根本原因。
期刊:Cell Reports
影响因子:6.9
doi:10.1016/j.celrep.2026.117063
Fleming, Andrew M; Jablonowski, Carolyn M; Jin, Hongjian; Zhang, Siwei; Sona, Surbhi; Lee, Ha Won; Dieseldorff Jones, Karissa M; Cheng, Changde; Xu, Beisi; Morton, Christopher L; Woolard, Mary A; Pichavaram, Prahalathan; Gehle, Daniel B; Natarajan, Sivaraman; Kodali, Kiran; Pagala, Vishwajeeth; High, Anthony A; Kumar, Yogesh; Burden, Steven; Valentine, Virginia; Daria, Deidre; Harbour, Jake; Vocelle, Daniel; Chang, Ti-Cheng; Easton, John; Olsen, Scott R; Neale, Geoffrey; Pinto, Emilia M; Rehg, Jerold E; Janke, Laura; Santiago, Teresa; George, Rani E; Ma, Xiaotu; Zambetti, Gerard P; Davidoff, Andrew M; Chen, Taosheng; Wu, Gang; Chen, Xiang; Yang, Jun; Murphy, Andrew J